• FirefoxInstall the new Firefox »
  •  Dow Down1.01% Nasdaq Down0.75%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    1.83 Up 0.41(28.87%) 11:40AM EST - Nasdaq Real Time Price
    Add to Portfolio
    HeadlinesGet Headlines for:
    [audio] [audio] AVEO Oncology Biomarker Analysis from Phase 2 Clinical Study of Tivozanib in Patients with Advanced Colorectal Cancer (recorded earlier today)

    No headlines available for AVEO prior to October 23, 2013.